Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment
Abstract Coronavirus disease 2019 (COVID‐19) is a global pandemic increasingly encountered in the clinical setting. It typically manifests as a respiratory illness, although cardiac involvement is common and portends a worse prognosis. We present the case of a 56‐year‐old male admitted with COVID‐19...
Main Authors: | Hawkins C. Gay, Arjun Sinha, Eriberto Michel, Anthony B. Mozer, Ashley Budd, Matthew J. Feinstein, Keith H. Benzuly, Abbas Al‐Qamari, Amit A. Pawale, Esther E. Vorovich |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13041 |
Similar Items
-
Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
by: Osnat Itzhaki Ben Zadok, MD, MS, et al.
Published: (2019-09-01) -
MUMPS MYOCARDITIS AS A CAUSE OF NEONATAL CARDIOGENIC SHOCK
by: M. Kadivar, et al.
Published: (2008-05-01) -
Case Report: Hypothyroidism Misdiagnosed as Fulminant Myocarditis in a Child
by: Nanjun Zhang, et al.
Published: (2021-06-01) -
Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review
by: Maya E. Guglin, et al.
Published: (2023-02-01) -
On the Precipice of Disaster – Fulminant Acute Myocarditis Mimicking ST-Elevation Myocardial Infarction in a Young Patient
by: Ruxandra DRAGOI GALRIHNO, et al.
Published: (2021-07-01)